|Robert A. Bettigole|
Entrepreneur in Residence
Robert Bettigole is the founder and managing partner of New Haven-based Elm Street Ventures, a seed and early stage venture capital firm. He currently serves as chairman of P2 Science and Samara Innovations, and is chairman & CEO of Occam Sciences. He is Elm Street’s observer on the BioRelix board, was previously a board member of ShareGrove and Retail Optimization Inc., and served as an observer on the boards of Affomix Corporation and Metagenomix.
Mr. Bettigole has a BS in Engineering and Applied Science from Yale University and an MPPM from the Yale School of Management, where he is an Entrepreneur-in-Residence. He is a licensed professional engineer and holds several U.S. and foreign patents.
Mr. Bettigole has served on the operating board of the Yale Entrepreneurial Institute since its founding in 2007 and is an active mentor of several businesses founded by Yale students. Mr. Bettigole has brought his venture capital experience to a number of Yale SOM classes, has served as an advisor for students undertaking for-credit independent study, and meets frequently with students eager to explore career choices as entrepreneurs or early-stage investors.
Mr. Bettigole’s venture capital experience was gained at Rothschild Ventures and Investor AB, where his investments included Maxim Integrated Products, Gensia Pharmaceuticals, and Microgenics Corporation. Subsequently, he helped found Surety Technologies, Inc., a spin out from Bellcore, and Alexion (NASDAQ: ALXN), with researchers from the Yale Medical School.